Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - metachloroxylenol; cresylic acid - aqueous concentrate - metachloroxylenol phenol active 20.0 g/l; cresylic acid phenol active 400.0 g/l - dermatological preps. - broiler & other deep litter sheds | cagelayer sheds,battery brooders,pigpens | horse,cattle stalls,livestock housing | battery b - bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

diversey australia pty. limited - iodine; phosphoric acid - emulsifiable concentrate - iodine mineral-iodine active 4.0 g/l; phosphoric acid mineral-phosphorus-acid active 680.0 g/l - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - linolenic acid; linoleic acid; docosahexaenoic acid; eicosapentaenoic acid - oral paste - linolenic acid acid-essential fatty active 120.0 mg/g; linoleic acid acid active 38.0 mg/g; docosahexaenoic acid acid-fatty active 59.0 mg/g; eicosapentaenoic acid acid-fatty active 85.0 mg/g - nutrition & metabolism - dog | bitch | castrate | puppy - allergic dermatitis | dermatoses - inflamation | atopy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tasman chemicals pty. limited - sulfamic acid - soluble powder - sulfamic acid mineral-sulfur-acid active 965.0 g/kg - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - tranexamic acid 500mg - film coated tablet - 500 mg - active: tranexamic acid 500mg excipient: basic butylated methacrylate copolymer colloidal silicon dioxide croscarmellose sodium isopropyl alcohol macrogol 8000 magnesium stearate   microcrystalline cellulose povidone purified talc   purified water titanium dioxide vanillin - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: -prostatectomy and bladder surgery -menorrhagia -epistaxis -conisation of the cervix - management of dental extraction in patients with coagulopathies - ulcerative colitis - haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma) -gastrointestinal haemorrhage general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: - in obstetrical complications such as abruptio placentae and post-partum haemorrhage - in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase hereditary angioneurotic oedema. for the reduction of peri– and post-operative blood loss and the need for blood transfusion in adult patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. for the reduction of peri- and post-operative blood loss and the need for blood transfusion in paediatric patients undergoing cardiac surgery.

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - alendronic acid - tablet - 70 milligram(s) - bisphosphonates; alendronic acid - bisphosphonates, for the treatment of bone diseases - treatment of postmenopausal osteoporosis. alendronic acid reduces the risk of vertebral and hip fractures.

United Kingdom - English - myHealthbox

crescent pharma ltd - folic acid - tablets - 5mg - folic acid and derivatives - folic acid is necessary for the normal production and maturation of blood cells, and is used in the treatment of nutritional megaloblastic anaemias eg. following gastrectomy and the megaloblastic anaemia of pregnancy. it may also be used prophylactically in chronic haemolytic states or in renal dialysis.

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - ibandronic acid - wounds and injuries; breast diseases; neoplastic processes; calcium metabolism disorders; water-electrolyte imbalance - drugs for treatment of bone diseases - ibandronic acid is indicated in adults forprevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.treatment of tumour induced hypercalcaemia with or without metastases.treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5.1).a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

European Union - English - EMA (European Medicines Agency)

sandoz gmbh - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases, bisphosphonates - ibandronic acid sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.,